Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3693138018 | Calamine 15 mg/g and dimethicone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | en | Synonym | Active | Case insensitive | SNOMED CT core |
3693139014 | Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
3693141010 | Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | en | Synonym | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Is a | Calamine- and dimeticone- and zinc oxide-containing product in cutaneous dose form | false | Inferred relationship | Some | ||
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Is a | Calamine and dimeticone and zinc oxide only product in cutaneous dose form | true | Inferred relationship | Some | ||
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Has precise active ingredient | Calamine | true | Inferred relationship | Some | 1 | |
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Has precise active ingredient | Zinc oxide | true | Inferred relationship | Some | 3 | |
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Has BoSS | Zinc oxide | true | Inferred relationship | Some | 3 | |
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Has BoSS | Calamine | true | Inferred relationship | Some | 1 | |
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Is a | Barrier preparation | false | Inferred relationship | Some | ||
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Is a | Calamine-containing product | false | Inferred relationship | Some | ||
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Has active ingredient | Dimeticone | false | Inferred relationship | Some | ||
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Has active ingredient | Zinc oxide | false | Inferred relationship | Some | ||
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Has active ingredient | Calamine | false | Inferred relationship | Some | ||
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Has active ingredient | Pharmaceutical base or inactive agent | false | Inferred relationship | Some | ||
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Has manufactured dose form | Cutaneous AND/OR transdermal dosage form | false | Inferred relationship | Some | ||
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Has manufactured dose form | Cream | false | Inferred relationship | Some | ||
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Is a | Calamine- and zinc oxide-containing product | false | Inferred relationship | Some | ||
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Is a | Dimeticone- and zinc oxide-containing product | false | Inferred relationship | Some | ||
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Has manufactured dose form | Cutaneous cream | true | Inferred relationship | Some | ||
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Is a | Calamine in topical dosage form | false | Inferred relationship | Some | ||
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Is a | Zinc in topical dosage form | false | Inferred relationship | Some | ||
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 1 | |
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 3 | |
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 2 | |
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Count of base of active ingredient | 3 | false | Inferred relationship | Some | ||
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 3 | |
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 3 | |
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Has concentration strength numerator value | 75 | false | Inferred relationship | Some | 1 | |
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Has precise active ingredient | Zinc oxide | false | Inferred relationship | Some | 1 | |
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Has BoSS | Zinc oxide | false | Inferred relationship | Some | 1 | |
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Has precise active ingredient | Calamine | false | Inferred relationship | Some | 3 | |
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Has BoSS | Dimeticone | true | Inferred relationship | Some | 2 | |
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Has precise active ingredient | Dimeticone | true | Inferred relationship | Some | 2 | |
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Has concentration strength numerator value | 15 | false | Inferred relationship | Some | 3 | |
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Has BoSS | Calamine | false | Inferred relationship | Some | 3 | |
Calamine 15 mg/g and dimeticone 200 mg/g and zinc oxide 75 mg/g cutaneous cream | Has concentration strength numerator value | 200 | false | Inferred relationship | Some | 2 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets